Skip to main content
. 2017 Apr 20;12(4):e0175897. doi: 10.1371/journal.pone.0175897

Table 2. Comparison of the aspects related to continuous dialysis between survivors and non-survivors.

Variables Survivors (78) Non-survivors (105) Total (183) P value
Dialysis prescribed dose (mL/kg/h) 37.6 (33–45.1) 38 (33.7–43.2) 37.9 (33.4–43.9) 0.86
Dialysis delivered dose (mL/kg/h) 32.8 (28.8–40) 33.6 (29.3–38.5) 33.2 (28.9–38.7) 0.88
Interruption time during CVVHDF (hours) 1 (0–8.6) 2 (0–15.8) 2 (0–10) 0,21
Number of days on CVVHDF 5 (3–8) 7 (3–12) 6 (3–10) 0.45
Time from ICU admission to starting time of CVVHDF (days) 1 (1–3) 2 (1–4) 2 (1–4) 0,01
Percentage change of weight from hospital admission to beginning of CVVHDF (%) 5.62 (0.82–12.13) 8.11 (0.95–17.97) 7.1 (1.0–15.4) 0.15
Fluid balance (cumulative) during dialysis (L) -4.13 (-7.78–-0.77) +0.65 (-3.68–+5.23) -1.84 (-5.74–+ 2.99) <0,001
Daily fluid balance during dialysis (L) -0.74 (-1.28–-0.17) -0.08 (-0.7–+1.0) -0.35 (-1.08–+0.43) <0,001

CVVHDF, continuous venovenous hemodiafiltration; ICU, intensive care unit. Categorical variables described by absolute value (percentage) and numeric variables described by median (IQR).

HHS Vulnerability Disclosure